Tela Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $18,957 | $16,091 | $16,603 | $16,998 |
Gross Profit | 12,858 | 11,073 | 11,336 | 11,624 |
EBITDA | -9,365 | -11,020 | -4,095 | -11,384 |
EBIT | -9,628 | -11,269 | -4,329 | -11,545 |
Net Income | -10,372 | -12,600 | -5,661 | -12,890 |
Net Change In Cash | 18,957 | 16,091 | 16,603 | 16,998 |
Free Cash Flow | -9,105 | -10,996 | -14,688 | -11,256 |
Cash | 17,301 | 26,496 | 37,143 | 46,729 |
Basic Shares | 24,703 | 24,663 | 24,579 | 24,490 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $58,453 | $41,418 | $29,463 | $18,213 |
Gross Profit | 40,112 | 27,044 | 18,813 | 11,234 |
EBITDA | -40,633 | -39,058 | -29,144 | -24,705 |
EBIT | -41,441 | -40,245 | -29,679 | -25,230 |
Net Income | -46,664 | -44,337 | -36,110 | -31,878 |
Net Change In Cash | 58,453 | 41,418 | 29,463 | 18,213 |
Cost of Revenue | -1,768 | -30,474 | ||
Free Cash Flow | -41,468 | -42,620 | -31,059 | -24,623 |
Cash | 46,729 | 42,019 | 43,931 | 74,394 |
Basic Shares | 22,868 | 16,267 | 14,473 | 12,934 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.42 |
2024-06-30 | -$0.51 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.53 |
